Comparative evaluation of the antidiabetic potential of three varieties of Ipomoea batatas L
- PMID: 40230512
- PMCID: PMC11995110
- DOI: 10.1016/j.toxrep.2025.102015
Comparative evaluation of the antidiabetic potential of three varieties of Ipomoea batatas L
Abstract
Sweet potato (Ipomoea batatas L.) is a nutrient-dense tuber often used in traditional diabetic treatment. This research compares the antidiabetic potential of three sweet potato varieties: orange-fleshed (OFSP), purple-peel white-fleshed (PPWSP), and white-peel white-fleshed (WPWSP), utilising in vitro and in vivo techniques. Sweet potatoes (OFSP, PPWSP, and WPWSP) boiled at 100°C for 20 minutes were incorporated into formulated diets and administered to streptozotocin-induced diabetic rats for 14 days. Aqueous extracts of the diets were tested in vitro for antioxidants and phytochemicals. Glycaemic control parameters, lipid profiles, oxidative stress indicators, and pancreatic histology were investigated. Gene expression analysis was performed on critical diabetes-related pathways. OFSP showed significant strong anti-diabetic benefits, including better glycemic control, weight maintenance, lower HOMA-IR scores, and lowered α-amylase and α-glucosidase activity. OFSP-fed rats had higher insulin, glycogen, and hexokinase activity than those given PPWSP and WPWSP. OFSP decreased mRNA expression of DPP-4 while increasing GLP-1 expression. OFSP also improved lipid profiles, increasing HDLc while decreasing LDLc and triglycerides more than other varieties. Histopathological examination revealed restorative effects in pancreatic beta cells. OFSP demonstrated more pronounced antidiabetic effects compared to PPWSP and WPWSP, particularly in terms of glycemic control, insulin regulation, and lipid profile improvement. These findings suggest that OFSP may offer significant potential for diabetes management. However, further clinical studies are needed to validate these results and explore the practical dietary applications of OFSP in diabetes control.
Keywords: Antioxidants; Diabetes; Dyslipidemia; Streptozotocin; Sweet potato.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Angelantonio Di, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging risk factors collaboration. Lancet. 2010;26(375):2215–2222. - PMC - PubMed
-
- Saing M., Harahap U., Sitorus P. Combination of purple sweet potato (Ipomea batatas) leaf extract with metformin on blood glucose and total cholesterol levels of rats induced by high-fat diet and streptozotocin. Int. J. Basic Clin. Pharmacol. 2024;13(2):1–5. doi: 10.18203/2319-2003.ijbcp20240001. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous
